SIA
PRCT icon

Sit Investment Associates’s Procept Biorobotics PRCT Stock Holding History

Sit Investment Associates’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34,840
Closed -$871K – 539
2026
Q1 		$871K Hold
34,840
– – 0.02% 372
2025
Q4 		$1.1M Hold
34,840
– – 0.02% 368
2025
Q3 		$1.24M Buy
34,840
+8,700
+33% +$397K 0.03% 353
2025
Q2 		$1.51M Hold
26,140
– – 0.03% 339
2025
Q1 		$1.52M Buy
26,140
+13,305
+104% +$908K 0.04% 334
2024
Q4 		$1.03M Buy
12,835
+3,835
+43% +$328K 0.02% 376
2024
Q3 		$721K Buy
+9,000
New +$639K 0.02% 408

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sit Investment Associates's PRCT Position: Q2 2026 in Review

Sit Investment Associates sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 34,840 shares — an estimated $871K sold.

Sit Investment Associates first reported a position in PRCT in Q3 2024 and held it in 7 quarters. The position peaked at $1.52M in Q1 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Sit Investment Associates reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Sit Investment Associates sold 34,840 Procept Biorobotics shares in Q2 2026, an estimated $871K.
  • Sit Investment Associates first reported a position in Procept Biorobotics in Q3 2024 and held it in 7 quarters.
  • Sit Investment Associates's Procept Biorobotics position peaked at $1.52M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.